Australia's Firebrick falls on withdrawing appeal for nasal spray approval

Firebrick Pharma

27/12/2023 03:28

** Shares of Firebrick Pharma  FRE.AX  fall as much as 3.9%
to A$0.050, posting their biggest intraday percentage decline
since Dec. 20
    ** Pharmaceutical co says it withdrew its appeal with
Australia's Administrative Appeals Tribunal 
    ** Co had appealed against the country's Therapeutic Goods
Administration's decision not to approve its Nasodine Nasal
Spray
    ** Stock down 77.4% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))